Adar1 Capital Management, LLC Cytom X Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 47,036 shares of CTMX stock, worth $98,775. This represents 0.01% of its overall portfolio holdings.
Number of Shares
47,036
Previous 145,036
67.57%
Holding current value
$98,775
Previous $149 Million
79.98%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding CTMX
# of Institutions
67Shares Held
44.8MCall Options Held
8.9KPut Options Held
47.9K-
Tang Capital Management LLC San Diego, CA6.72MShares$14.1 Million0.28% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$11 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.12MShares$10.7 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.93MShares$8.25 Million0.9% of portfolio
-
Acadian Asset Management LLC Boston, MA3.14MShares$6.59 Million0.01% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $138M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...